SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Sep-24 5:10 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Sep-24 | Private Sale | 1,738 | $26.18 | $45,500.80 | (< 1%) 607.15K to 605.42K | |
20-Aug-24 11:45 AM View: | Akero Therapeutics, Inc. (AKRO) | 16-Aug-24 | Option Exercise | 24,538 | $0.62 | $15,090.90 | 4% 582.62K to 607.15K | |
13-Jun-24 6:01 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Jun-24 | Private Sale | 7,894 | $22.64 | $178,728.00 | (1%) 589.45K to 581.55K | |
15-Mar-24 4:43 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Mar-24 | Private Sale | 1,969 | $28.33 | $55,781.80 | (< 1%) 591.42K to 589.45K | |
06-Mar-24 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Mar-24 | Option Exercise | 75,000 | $17.17 | $1,288,060.00 | 13% 591.42K to 666.42K | |
06-Mar-24 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Mar-24 | Planned Option Sale | 75,000 | $32.87 | $2,465,060.00 | (11%) 666.42K to 591.42K | |
03-Jan-24 5:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Jan-24 | Option Exercise | 40,000 | $0.62 | $24,600.00 | 7% 550.91K to 590.91K | |
18-Dec-23 8:37 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Dec-23 | Market Sale | 1,628 | $20.76 | $33,797.30 | (< 1%) 552.54K to 550.91K | 5% |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Dec-23 | Option Exercise | 7,405 | $6.36 | $47,095.80 | 1% 552.54K to 559.94K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Dec-23 | Planned Option Sale | 7,405 | $20.02 | $148,273.00 | (1%) 559.94K to 552.54K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Grant | 91,541 | -- | -- | 20% 461.0K to 552.54K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Option Exercise | 12,873 | $6.36 | $81,872.30 | 2% 552.54K to 565.41K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Planned Option Sale | 12,873 | $20.01 | $257,571.00 | (2%) 565.41K to 552.54K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 07-Dec-23 | Option Exercise | 6,700 | $6.36 | $42,612.00 | 1% 461.0K to 467.7K | |
11-Dec-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 07-Dec-23 | Planned Option Sale | 6,700 | $20.02 | $134,125.00 | (1%) 467.7K to 461.0K | |
04-Oct-23 8:41 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Oct-23 | Option Exercise | 25,000 | $6.36 | $159,000.00 | 5% 461.0K to 486.0K | |
04-Oct-23 8:41 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Oct-23 | Planned Option Sale | 25,000 | $47.91 | $1,197,830.00 | (5%) 486.0K to 461.0K | |
25-Sep-23 8:36 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-23 | Private Sale (Planned) | 1,682 | $50.34 | $84,671.90 | (< 1%) 462.68K to 461.0K | |
18-Sep-23 6:48 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Sep-23 | Option Exercise | 25,000 | $6.36 | $159,000.00 | 5% 462.68K to 487.68K | |
18-Sep-23 6:48 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Sep-23 | Planned Option Sale | 25,000 | $49.77 | $1,244,250.00 | (5%) 487.68K to 462.68K | |
30-Aug-23 7:04 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Aug-23 | Option Exercise | 15,000 | $0.62 | $9,225.00 | 3% 447.68K to 462.68K | |
03-Aug-23 4:13 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Aug-23 | Option Exercise | 25,000 | $6.36 | $159,000.00 | 6% 447.68K to 472.68K | |
03-Aug-23 4:13 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Aug-23 | Planned Option Sale | 25,000 | $43.15 | $1,078,870.00 | (5%) 472.68K to 447.68K | |
06-Jul-23 8:44 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jul-23 | Option Exercise | 25,000 | $6.36 | $159,000.00 | 6% 447.68K to 472.68K | |
06-Jul-23 8:44 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jul-23 | Planned Option Sale | 25,000 | $44.88 | $1,122,040.00 | (5%) 472.68K to 447.68K | |
27-Jun-23 7:12 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Jun-23 | Option Exercise | 40,000 | $0.62 | $24,600.00 | 10% 407.68K to 447.68K | |
15-Jun-23 9:38 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jun-23 | Private Sale (Planned) | 1,613 | $55.16 | $88,973.10 | (< 1%) 409.29K to 407.68K | |
05-Jun-23 6:23 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Jun-23 | Option Exercise | 25,000 | $1.46 | $36,459.20 | 6% 409.29K to 434.29K | |
05-Jun-23 6:23 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Jun-23 | Planned Option Sale | 25,000 | $45.10 | $1,127,430.00 | (6%) 434.29K to 409.29K | |
03-May-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-May-23 | Option Exercise | 25,000 | $0.62 | $15,375.00 | 6% 409.29K to 434.29K | |
03-May-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-May-23 | Planned Option Sale | 25,000 | $45.07 | $1,126,860.00 | (6%) 434.29K to 409.29K | |
03-May-23 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 18-Apr-23 | Option Exercise | 40,000 | $0.62 | $24,600.00 | 11% 369.29K to 409.29K | |
05-Apr-23 4:55 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Apr-23 | Option Exercise | 25,000 | $0.62 | $15,375.00 | 7% 369.29K to 394.29K | |
05-Apr-23 4:55 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Apr-23 | Planned Option Sale | 25,000 | $37.94 | $948,576.00 | (6%) 394.29K to 369.29K | |
14-Mar-23 4:18 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Mar-23 | Payment of Exercise | 1,706 | $43.47 | $74,159.80 | (< 1%) 371.0K to 369.29K | |
03-Mar-23 4:21 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Mar-23 | Option Exercise | 25,000 | $0.62 | $15,375.00 | 7% 371.0K to 396.0K | |
03-Mar-23 4:21 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Mar-23 | Planned Option Sale | 25,000 | $46.65 | $1,166,340.00 | (6%) 396.0K to 371.0K | |
03-Feb-23 5:25 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Feb-23 | Option Exercise | 25,000 | $0.62 | $15,375.00 | 7% 371.0K to 396.0K | |
03-Feb-23 5:25 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Feb-23 | Planned Option Sale | 25,000 | $49.06 | $1,226,400.00 | (6%) 396.0K to 371.0K | |
05-Jan-23 6:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jan-23 | Option Exercise | 25,000 | $0.62 | $15,375.00 | 7% 371.0K to 396.0K | |
05-Jan-23 6:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jan-23 | Planned Option Sale | 25,000 | $51.27 | $1,281,750.00 | (6%) 396.0K to 371.0K | |
20-Dec-22 7:46 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Dec-22 | Option Exercise | 8,500 | $0.62 | $5,227.50 | 2% 362.5K to 371.0K | |
13-Dec-22 8:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 09-Dec-22 | Grant | 52,351 | -- | -- | 17% 310.15K to 362.5K | |
02-Dec-22 5:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Dec-22 | Option Exercise | 10,000 | $0.62 | $6,150.00 | 3% 310.15K to 320.15K | |
02-Dec-22 5:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Dec-22 | Planned Option Sale | 10,000 | $46.07 | $460,700.00 | (3%) 320.15K to 310.15K | |
02-Nov-22 9:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Nov-22 | Option Exercise | 10,000 | $0.62 | $6,150.00 | 3% 310.15K to 320.15K | |
02-Nov-22 9:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Nov-22 | Planned Option Sale | 10,000 | $43.42 | $434,183.00 | (3%) 320.15K to 310.15K | |
05-Oct-22 8:55 AM View: | Akero Therapeutics, Inc. (AKRO) | 03-Oct-22 | Option Exercise | 10,000 | $0.62 | $6,150.00 | 3% 310.15K to 320.15K | |
05-Oct-22 8:55 AM View: | Akero Therapeutics, Inc. (AKRO) | 03-Oct-22 | Planned Option Sale | 10,000 | $33.23 | $332,278.00 | (3%) 320.15K to 310.15K | |
15-Sep-22 7:59 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-22 | Option Exercise | 60,000 | $0.62 | $36,900.00 | 19% 310.15K to 370.15K |